Pepdexpepdex
Stack
← All compounds

Matrixyl 3000

Palmitoyl tripeptide-1 + tetrapeptide-7, palmitoyl pentapeptide-4, Argireline, Matrixyl · Cosmetic peptide (topical)

Research reference only. Pepdex does not sell, supply or track this compound, and nothing here is guidance to use it — this page exists so the evidence and the risks are visible.

What it is

The flagship anti-wrinkle peptide complex in commercial skincare — Matrixyl 3000 is palmitoyl tripeptide-1 plus palmitoyl tetrapeptide-7 (the original Matrixyl is palmitoyl pentapeptide-4), designed to signal collagen production through the skin. Often formulated alongside Argireline, a separate cosmetic peptide.

How it works

Matrixyl is a family of cosmetic peptides — palmitoyl pentapeptide-4 and related sequences — attached to a fatty acid chain to help them cross the skin barrier. The proposed mechanism is that these short peptide fragments mimic pieces of collagen breakdown products, which the skin reads as a signal that repair is needed, prompting increased collagen synthesis. That is a plausible signalling idea and it is worth being clear about the scale: this is a cosmetic ingredient making a structural claim, and the evidence behind it is mostly manufacturer-supported.

What human evidence shows

Manufacturer-funded studies and small published trials show measurable wrinkle-depth improvements over 8-12 weeks — better evidence than most cosmetic ingredients, weaker than any drug standard. The palmitoyl tail is legitimate penetration chemistry.

The studies, one by one

  • LIMITED. Small studies, largely funded or conducted by ingredient manufacturers, report modest improvements in wrinkle depth and skin roughness over weeks to months.
  • Independent replication is thin, sample sizes are small, and skin appearance endpoints are unusually sensitive to placebo and to the moisturiser base the peptide is delivered in.
  • NONE SHOWN against the comparison that matters: no trial establishes it performs comparably to tretinoin, which has decades of randomised photoageing evidence.
  • Penetration is the unresolved practical question — a peptide has to reach the dermis to signal collagen production, and how much of an applied dose gets there from a leave-on cosmetic is not well characterised.
  • It is a cosmetic ingredient rather than a drug, so it is not subject to efficacy review before sale.

Half-life and how long it lasts

Applied topically in a leave-on formulation. The palmitoyl chain exists to improve penetration through the skin barrier. Effects, where reported, take weeks to months and require continued use. Concentration in finished products varies widely and is often not disclosed, so two products naming the same peptide are not comparable.

Risks

Topical and low-stakes: occasional irritation or sensitivity, and premium pricing on modest effects. Products made outside cosmetic manufacturing standards carry contamination and concentration uncertainty that finished retail products do not.

Who should never touch it

  • Anyone expecting results comparable to a prescription retinoid
  • Anyone with a known sensitivity to the formulation
  • Anyone spending significantly on it in preference to interventions with real evidence — sunscreen and tretinoin being the two with the strongest photoageing data

Interactions worth knowing

  • Generally well tolerated alongside other topicals.
  • Nothing established at the level of a drug interaction — it is a cosmetic ingredient.

What a clinician would watch

  • Photographs under consistent lighting, because slow skin change is not something memory judges accurately.
  • Irritation or contact dermatitis, which is uncommon for this ingredient but possible with any leave-on product.
  • Whether the product actually states a concentration, since most do not.

What stopping looks like

No withdrawal and no rebound. Any effect fades over weeks as skin returns to its untreated state, which is true of essentially every topical in this category. Since the effect size is modest and the evidence limited, there may be little to notice on stopping.

Myth vs evidence

“It is a needle-free alternative to injectables or a replacement for retinoids.”

No trial supports either comparison. Tretinoin has decades of randomised evidence for photoageing; this has small, largely manufacturer-supported studies.

“Peptides signal collagen production, so more concentration is better.”

Concentration is usually undisclosed, penetration to the dermis is poorly characterised, and no dose-response relationship has been established in skin.

“The results in the studies are the results you will get.”

Skin appearance endpoints are highly placebo-sensitive, and much of the measured improvement in cosmetic trials comes from the moisturiser base rather than the active.

Legal status

US: cosmetic ingredient — not subject to FDA drug preapproval, but cosmetics and their manufacturers remain regulated under federal cosmetics law.

Evidence base

C34 research papers
emerging literature

Early human evidence: at least one human trial report, and not much beyond it.

phase 3/4
0
randomised
1
reviews
0
human trials
3

Counts are of published papers, not distinct trials, and they nest rather than add up: PubMed files every randomised trial as a clinical trial too. They measure how much research exists — not whether this works or is safe for you.

Research (12)

Turn Matrixyl 3000 into a plan that's yours

The info above is free. Membership makes it personal, the Coach answers questions about your exact stack, the Stack tracks it for you, and the Verified Sources shows you how to vet what you buy.

  • ✓ AI Coach, ask anything about your stack. It does the dosing math, flags interactions, and tells you what to do next.
  • ✓ Personal Stack, save your protocol, track it across devices, log doses, get a heads-up before a vial runs out.
  • ✓ Verified Sources, the vetted reference for checking quality and sourcing, members only.
Become a member, from $4.99/week

Cancel anytime · or save with $59.99/yr · Coach + Stack included

Where next

Every compound in the catalogThe full non-peptide index, with evidence grades.→The peptide indexInjectable peptides, half-lives and what trials used.→Spotting a scam vendorRed flags, COA checks and what traceability looks like.→